Neurochemical research division

Pioneering the science
of human potential.
Through chemistry.

M

Merzer Pharmaceuticals is advancing neurochemical innovation to unlock the full potential of the human mind. Our compounds. Our research. Our future.

Merzer NewsPhase III nocturnal cognition study initiatedView all →

Precision compound platforms

Formulated at the frontier of sleep and cognition.

Our fictional pipeline pairs distinct delivery profiles with targeted nocturnal research programs. Explore the science, then discover the officially licensed collector-candy editions in the Merzer store.

Merzer compound tablets

Our compounds & field issue

Engineered for the mind. Designed for those who entered Building Z.

Methanan™ and Thanameth™ store products contain novelty candy and are not drugs, medicine, supplements, or treatments.

Beyond conventional pharmaceutical development

Merzer is building an integrated biotechnology platform for the sleeping mind.

Our model combines neurochemistry, biometric sensing, controlled-environment research, adaptive analytics, and precision compound development. We do not treat sleep as inactivity. We treat it as an accessible biological system—measurable, programmable, and capable of transforming human performance.

24

Active research protocols

11

Neurochemical pathway programs

4

Integrated research facilities

1

Singular frontier

Corporate structure

Merzer Pharmaceuticals — an MP Corp subsidiary

MP Corp’s life-sciences portfolio integrates research infrastructure, advanced materials, data systems, and neurotechnology under a single long-horizon development strategy.

Unwavering integrity

Clinical excellence. Ethical standards.

Advanced science

Pushing the boundaries of nocturnal research.

Patient privacy

Your data. Our responsibility.

Beyond possible

We do not follow the future. We create it.